ASP Isotopes Inc. reported $31M of revenue over the trailing twelve months, +573% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $31M (to Q2 2026). Net income: −$117M, trailing twelve months to Q2 2026. Free cash flow: −$84M, trailing twelve months to Q2 2026. Operating margin: −430%, trailing twelve months to Q2 2026.

ASPIASP Isotopes Inc.

Basic Materials

$2.66-71% 1Y

$2.66

$2.6052 weeks$14.05

ASPI as reported

ASP Isotopes Inc. reported $31M of revenue over the trailing twelve months, +573% on the year before. 10 reported series are charted on this page, each one as filed.

$31M

Revenue, trailing twelve months · to Q2 2026 · +573% against the twelve months before

Net income: −$117M
Net income · +17% year on year · trailing twelve months to Q2 2026
Free cash flow: −$84M
Free cash flow · +182% year on year · trailing twelve months to Q2 2026
Operating margin: −430%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ASPI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$31M	+573%	Q2 2026
Net income	−$117M	+17%	Q2 2026
EPS	−$1.32	−5.7%	Q2 2026
Gross margin	22%	n/a	Q2 2026
Operating margin	−430%	n/a	Q2 2026
Net margin	−369%	n/a	Q2 2026
ROE	−80%	n/a	Q2 2026
ROA	−32%	n/a	Q2 2026
ROIC	−18%	n/a	Q2 2026
Free cash flow	−$84M	+182%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.